Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer

Advanced melanoma and non-melanoma skin cancers (NMSCs) are burdened with a dismal prognosis. To improve the survival of these patients, studies on immunotherapy and target therapies in melanoma and NMSCs are rapidly increasing. BRAF and MEK inhibitors improve clinical outcomes, and anti-PD1 therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubatto, Marco, Sciamarrelli, Nadia, Borriello, Silvia, Pala, Valentina, Mastorino, Luca, Tonella, Luca, Ribero, Simone, Quaglino, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947410/
https://www.ncbi.nlm.nih.gov/pubmed/36844955
http://dx.doi.org/10.3389/fmed.2022.959289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947410/
https://www.ncbi.nlm.nih.gov/pubmed/36844955
http://dx.doi.org/10.3389/fmed.2022.959289

Ejemplares similares